| What you have | What it can support | What it cannot do |
|---|---|---|
| A priced round with institutional investors | Context for the work, nothing more | Satisfy any of the 8 criteria on its own |
| Coverage of the round | Published material about you, if you are the subject | Count when the story is about the company and quotes you once |
| A high salary or founder pay package | High remuneration, if benchmarked against peers | Substitute for a benchmark, or borrow credibility from valuation |
| A product with paying customers | Original contributions, through adoption and revenue impact | Prove adoption without a third party who will confirm it |
| A board seat | A governance role in your own company | Stand in for a peer group, an awarding body or a publisher |
| An investor letter | Very little | Act as independent expert assessment from someone with money at stake |
The short answer: a raise is not a criterion
You closed a round, the announcement went out and the company is real. None of that appears among the 8 criteria, and officers do not read it as a shortcut.
The O-1A is the extraordinary ability subcategory for the sciences, education, business and athletics. It asks about standing in a field, not about capital.
The standard is whether you are one of the small percentage who have arisen to the very top of the field of endeavor, and funding shows that investors expect a return rather than that the field has recognised you.
Money does something real for a file, but it works indirectly and slowly. It buys the product, the hiring and the coverage that later become evidence, and it is not evidence by itself.
You need a major internationally recognised award, or at least 3 of the 8 criteria, with 3 as a floor rather than a target. A round moves none of those numbers.
Founders see funded peers get approved and conclude that the round did the work, when the approval more often rests on the adoption and the coverage the money made possible. Cause and sequence differ.
What follows is what a raise can support, what it cannot, and how to spend the money so the record gets stronger.
What the 8 criteria ask for that capital cannot buy
Every criterion has the same shape, in that somebody outside your company decided something about you: an award jury, an editor, a conference committee, a customer or a peer group.
Capital is decided by investors, who are a party to the transaction rather than a field, which is why a term sheet reads as a deal and not as recognition.
Take original contributions, the criterion most founders rely on. The test is adoption by people who did not work for you, shown through licences, standards, products, citations or revenue impact.
Money can produce adoption, since a funded product can reach users, sign partners and earn revenue. The criterion is satisfied by the adoption rather than by the funding that made it possible.
Judging is the criterion capital cannot touch at all, since serving on a jury, a programme committee or a review panel is work someone has to invite you to do.
Review happens in 2 steps, and the second is where a round can be mentioned without deciding anything, since the final merits determination weighs the whole record rather than a single exhibit. Context is not credit.
Authorship is similar. A paper, a technical standard or a bylined body of work takes time, and no round shortens it.
Published material about you can be bought, which is exactly why bought coverage does not work. A profile you commissioned is not independent recognition, however good the outlet.
Where a round does help, and how to use it
The clearest benefit is coverage, but only when you are the story, since a funding announcement that names you as founder and describes what you built can support published material about you.
A company announcement that quotes you once does not. The criterion wants material about the person and their work, not coverage of a company that mentions a name.
The second benefit is adoption you can document. A funded product can sign customers, integrate with platforms and reach users, and each of those leaves a record a third party can confirm.
A funded team also produces collaboration you can document, since the engineers, designers and researchers you hire can co-author standards, papers and open source work with your name on it. That is authorship earned through the company.
A raise also lets you take a salary that reflects your market. High remuneration is a criterion, evidenced by contracts or reliable evidence benchmarked against peers in the same field.
That benchmark is the part founders skip. A number is not high in the abstract, only relative to what people doing your work earn in your market.
Customers are the strongest asset a funded company has, because a named customer who will describe the change in writing is exactly the third-party account an officer is looking for. Ask early, while the result is fresh.
The third benefit is time, which is the one people undervalue. A round buys you 12 months to judge, publish, speak and let a product earn adoption.
What does not count, and why officers discount it
Valuation is the most common mistake. A company worth a lot of money says what investors paid for equity, and it says nothing about your standing in a field.
Board seats fail for a similar reason. A seat is a governance role inside your own company, and it is not a peer group, an awarding body or a publisher.
A famous fund does not transfer its reputation to you, in the same way that a famous client does not transfer theirs to the agency that served it. The officer reads your record.
Investor letters are the weakest exhibit in founder files. The writer has money at stake, which makes the letter a statement of interest rather than an assessment by a disinterested expert.
Accelerator names do not help on their own. Being selected is an achievement, but the programme is not an association that judges achievement, and it is not a prize in the field.
Funding coverage that mentions you in passing does not count either. If the story is about the round and your name appears in paragraph 4, you are not the subject.
Why do officers discount all of it so consistently? Because each item is either a transaction you were part of or material your side produced.
The criteria are built to find recognition that arrived without your involvement, and a raise is the opposite of that by design.
The founder pattern that works, and the one that stalls
The pattern that works looks boring. The company ships something specific, a defined group of users depends on it, and that dependency is documented by the users.
Then the founder appears in the field rather than on the funding pages: a conference programme, an award jury, a technical standard, a trade publication that interviews them about the method.
By the time the petition is filed, the round is background. It explains why the product exists, and the evidence of standing comes from somewhere else.
The pattern that stalls has better press and a thinner file. A large round, a valuation story and a founder who has not yet been judged by anyone outside the company.
The tell is easy to spot in a document review: every exhibit is dated within the same 8 weeks and every one was written by someone on the payroll. Breadth of coverage hides that for a while.
Officers see this often enough that a funding headline carries almost no weight. What they look for is the second paragraph of the story, where someone else describes what changed.
If your file is 6 months of coverage and no external adoption, the round has not helped yet. It has bought you the time to fix that.
What to do with the money: 12 months of evidence
Start with the criterion you can move fastest, which for most founders is judging. Apply for award juries and conference programme committees, and keep the acceptance letters.
Months 1 to 3 should go to the things with a long lead time, because a jury invitation or an editorial letter cannot be produced on demand later. Lead time is the constraint.
Then document adoption as it happens rather than after. Customer names with permission, integration partners, platform listings, revenue figures a finance lead will confirm in writing.
Give your customers a reason to say something on the record, whether that is a case study, a conference talk with your user or a joint technical note that puts a third party's name next to the change.
Publish the method rather than the milestone. A technical standard, an open-source component or a paper with an academic collaborator all last longer than a launch post.
Keep one folder from day one, with a subfolder per criterion, and drop documents in as they arrive. Rebuilding 3 years of evidence from email is how strong records become weak files.
Take the salary you are worth and keep the benchmark. If you pay yourself below market to look committed, you have removed one criterion from your own file.
Be careful with the money, because it also builds the wrong file quickly. A round can produce 30 articles about the company in a month, none of them about you.
An approved O-1A petition is valid for up to 3 years with extensions in 1-year increments, and time on O-1 creates no green card queue position. The record you build in the first year is the one that gets extended.
Questions this raises
Does raising a round help an O-1A?
Not directly. Funding is not among the 8 criteria, and a term sheet is a transaction rather than recognition by a field. It helps indirectly when it produces coverage about you, documented adoption, or a salary you can benchmark against peers.
Can venture funding count as a prize or award?
No. The awards criterion asks for prizes recognised nationally or internationally for excellence in the field. An investment is not a prize, and investors are not an awarding body, however selective the round felt. Awards are competitive by design and rounds are not.
Can investor letters support my case?
Rarely, and not as evidence of standing. An investor has money at stake, so the letter reads as a statement of interest. Letters from experts who did not work for you carry far more weight with an officer. What it cannot do is stand in for a peer who has no stake in the outcome.
Does a high valuation count as high remuneration?
No. Valuation describes the company, and the criterion is about the salary or other remuneration you command. You need contracts or reliable evidence, benchmarked against peers in the same field. A founder salary below market weakens that argument rather than strengthening it.
Can a founder file without a petitioner?
No. O-1 classification requires a petitioner, which can be an employer or an agent, and there is no self-petition route. A company is often the petitioner, and an agent is common where a founder works across several entities. The petitioner signs the filing, so the entity has to exist before the petition does.
What should I do with the money instead?
Spend it on things that leave third-party records: customers who will confirm adoption, programmes that invite you to judge, publications that interview you about the method. The round is leverage rather than evidence. Anything only your own team can confirm is not evidence yet.